Related Experiment Videos
Clarification. Drug therapy for hyperlipidemia: when reducing cardiovascular risk is a priority
Postgraduate Medicine
|June 1, 1992
Summary
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Chitin-glucan fiber effects on oxidized low-density lipoprotein: a randomized controlled trial.
European journal of clinical nutrition·2012
Rate and risk predictors for development of self-reported type-2 diabetes mellitus over a 5-year period: the SHIELD study.
International journal of clinical practice·2012
Phentermine/topiramate for weight reduction and treatment of adverse metabolic consequences in obesity.
Drugs of today (Barcelona, Spain : 1998)·2012
The Bile Acid Sequestrant Acceptability scale validation study.
International journal of clinical practice·2010
Adiposopathy and bariatric surgery: is 'sick fat' a surgical disease?
International journal of clinical practice·2009
Ponatinib in CML and Ph+ ALL: balancing high efficacy with vascular safety.
Postgraduate medicine·2026
CV risk: if you aren't testing ACR, you aren't seeing the full picture.
Postgraduate medicine·2026
Anti-TNF-induced vasculitis: analysis of data from the French national pharmacovigilance database.
Postgraduate medicine·2026
Novel Lipoprotein (a) Therapies: A Comprehensive Review.
Current atherosclerosis reports·2026
Deactivation of Cardiac Devices at the End of Life: Clinical and Ethical Challenges.
Current heart failure reports·2026
Left Atrial Strain Prediction of New-Onset Atrial Fibrillation in Apical Hypertrophic Cardiomyopathy with Cardiac MRI.
Radiology. Cardiothoracic imaging·2026